Affiliation:
1. Department of Neurosurgery, Aleppo University Hospital, Aleppo University
2. Department of Dermatology and Venereology, Aleppo University Hospital, Aleppo, Syria
Abstract
Introduction:
Linear IgA bullous dermatosis (LABD) is a rare acquired skin blistering autoimmune disease. It can be diagnosed by confirming the presence of a linear band of IgA at the dermoepidermal junction on direct immunofluorescence microscopy. LABD can be characterized by vesicular lesions, diffuse blisters, or even as a mimicker of Steven–Johnson syndrome. LABD may be caused by tumours, infections, or drugs (amiodarone, furosemide, phenytoin, however, vancomycin is the potential inciting drug in most reports).
Case presentation:
The authors present here a case of a 61-year-old woman with a history of HTN. The patient had a discectomy 15 years ago, and also underwent a lumbar fusion surgery that resulted in complications with her discitis. Due to the complications from the surgery, intravenous treatment with vancomycin and meropenem was initiated. After a few days of treatment, the patient developed clear, tense, fluid-filled bullae over the upper extremities. Immunofluorescence microscopy is not available in our hospital. Therefore a diagnosis of vancomycin-induced LABD was proposed based on the clinical manifestation of the lesions and the coincidence with vancomycin administration. After 2 days of discontinuing the administration of vancomycin and applying local diprosone, the lesions started to regress and a full recovery was achieved on day 10.
Discussion and conclusion:
Even though drug-induced LABD is uncommon, its incidence has been steadily increasing in the last few years. LABD is a simple condition with a good prognosis and full recovery after the discontinuation of vancomycin
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference23 articles.
1. Sever vancomycin-induced linear IgA bullous dermatosis case report. sn comprehensive;Bawadkji;Clin Medicine,2022
2. Vancomycin-induced linear IgA bullous dermatosis: a case report and review of the literature;Kang;Ann Dermatol,2008
3. Vancomycin-induced linear IgA bullous dermatosis;Wiggins;Proc (Bayl Univ Med Cent),2021
4. Vancomycin: parenteral dosing, monitoring, and adverse effects in adults: introduction;Drew;Up to date,2022